Saggar Rajeev sold $263K of LQDA
Saggar Rajeev (Chief Medical Officer) sold 9,218 shares of Liquidia Corp (LQDA) at $28.48 ($0.26M total) on 2026-10-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a data point for investors monitoring insider activity but is unlikely to move the stock significantly.
Market read
Provides a fresh insider transaction record; modest relevance for short-term traders.
What to watch
The 10b5-1 plan suggests pre-scheduled execution, reducing the informational content of the trade.
Background
SEC Form 4 filings disclose insider transactions; this filing reports a sale by the company's Chief Medical Officer.
Ticker impact
Chief Medical Officer Saggar Rajeev sold 9,218 shares of Liquidia Corp for $262,528.64 in a Form 4 filing.
likely modest pressure as the market prices in the insider sell.
The sale size is modest relative to market cap, but insider disposals can be viewed negatively by investors.
Market effects
Minimal impact on the biotech sector; insider sales are common and not sector-wide.
No significant regional effect.
Limited to investors tracking Liquidia Corp.
Counterpoint
The sale could be routine portfolio rebalancing and not indicative of negative fundamentals.
Key entities
- CompanyLiquidia Corp
US-listed biotech company (ticker LQDA).
- IndividualSaggar Rajeev
Chief Medical Officer of Liquidia Corp.
